Dyslipidemiat, näytönastekatsausten kirjallisuusviitteet
Lisätietoa aiheesta
Käypä hoito -toimitus
27.10.2020
Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Dyslipidemiat
«Dyslipidemiat»1 näytönastekatsauksissa arvioitu kirjallisuus.
Kirjallisuutta
- Abdelhamid AS, Brown TJ, Brainard JS ym. Omega-3 fatty acids for the primary and secondary
prevention of cardiovascular disease. Cochrane Database Syst Rev 2018;7:CD003177 «PMID: 30019766»PubMed
- ACCORD Study Group., Ginsberg HN, Elam MB ym. Effects of combination lipid therapy
in type 2 diabetes mellitus. N Engl J Med 2010;362:1563-74 «PMID: 20228404»PubMed
- AHA., ACC., National Heart, Lung, and Blood Institute. ym. AHA/ACC guidelines for
secondary prevention for patients with coronary and other atherosclerotic vascular
disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J
Am Coll Cardiol 2006;47:2130-9 «PMID: 16697342»PubMed
- Alexander DD, Miller PE, Van Elswyk ME ym. A Meta-Analysis of Randomized Controlled
Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain
Omega-3 Fatty Acids and Coronary Heart Disease Risk. Mayo Clin Proc 2017;92:15-29
«PMID: 28062061»PubMed
- Amarenco P, Bogousslavsky J, Callahan A 3rd ym. High-dose atorvastatin after stroke
or transient ischemic attack. N Engl J Med 2006;355:549-59 «PMID: 16899775»PubMed
- Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and
updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009;8:453-63
«PMID: 19375663»PubMed
- American Diabetes Association.. Standards of medical care in diabetes--2013. Diabetes
Care 2013;36 Suppl 1:S11-66 «PMID: 23264422»PubMed
- ASCEND Study Collaborative Group., Bowman L, Mafham M ym. Effects of n-3 Fatty Acid
Supplements in Diabetes Mellitus. N Engl J Med 2018;379:1540-1550 «PMID: 30146932»PubMed
- Aung PP, Maxwell HG, Jepson RG ym. Lipid-lowering for peripheral arterial disease
of the lower limb. Cochrane Database Syst Rev 2007;:CD000123 «PMID: 17943736»PubMed
- Baigent C, Keech A, Kearney PM ym. Efficacy and safety of cholesterol-lowering treatment:
prospective meta-analysis of data from 90,056 participants in 14 randomised trials
of statins. Lancet 2005;366:1267-78 «PMID: 16214597»PubMed
- Bhatt DL, Steg PG, Miller M ym. Cardiovascular Risk Reduction with Icosapent Ethyl
for Hypertriglyceridemia. N Engl J Med 2019;380:11-22 «PMID: 30415628»PubMed
- Braamskamp MJAM, Langslet G, McCrindle BW ym. Effect of Rosuvastatin on Carotid Intima-Media
Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON
Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
Circulation 2017;136:359-366 «PMID: 28592434»PubMed
- Bruckert E, Labreuche J, Deplanque D ym. Fibrates effect on cardiovascular risk is
greater in patients with high triglyceride levels or atherogenic dyslipidemia profile:
a systematic review and meta-analysis. J Cardiovasc Pharmacol 2011;57:267-72 «PMID: 21052016»PubMed
- Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke.
A meta-analysis of randomized, controlled trials. Ann Intern Med 1998;128:89-95 «PMID: 9441587»PubMed
- Cannon CP, Blazing MA, Giugliano RP ym. Ezetimibe Added to Statin Therapy after Acute
Coronary Syndromes. N Engl J Med 2015;372:2387-97 «PMID: 26039521»PubMed
- Cannon CP, Braunwald E, McCabe CH ym. Intensive versus moderate lipid lowering with
statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504 «PMID: 15007110»PubMed
- Cannon CP, Steinberg BA, Murphy SA ym. Meta-analysis of cardiovascular outcomes trials
comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438-45
«PMID: 16875966»PubMed
- Cholesterol Treatment Trialists' (CTT) Collaborators., Mihaylova B, Emberson J ym.
The effects of lowering LDL cholesterol with statin therapy in people at low risk
of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet
2012;380:581-90 «PMID: 22607822»PubMed
- Cholesterol Treatment Trialists' (CTT) Collaborators., Kearney PM, Blackwell L ym.
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised
trials of statins: a meta-analysis. Lancet 2008;371:117-25 «PMID: 18191683»PubMed
- Cholesterol Treatment Trialists' Collaboration.. Efficacy and safety of statin therapy
in older people: a meta-analysis of individual participant data from 28 randomised
controlled trials. Lancet 2019;393:407-415 «PMID: 30712900»PubMed
- Cholesterol Treatment Trialists’ (CTT) Collaboration., Baigent C, Blackwell
L ym. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis
of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81
«PMID: 21067804»PubMed
- Colhoun HM, Betteridge DJ, Durrington PN ym. Primary prevention of cardiovascular
disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes
Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96
«PMID: 15325833»PubMed
- Collins R, Armitage J, Parish S ym. MRC/BHF Heart Protection Study of cholesterol-lowering
with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
Lancet 2003;361:2005-16 «PMID: 12814710»PubMed
- Collins R, Reith C, Emberson J ym. Interpretation of the evidence for the efficacy
and safety of statin therapy. Lancet 2016;388:2532-2561 «PMID: 27616593»PubMed
- de Lemos JA, Blazing MA, Wiviott SD ym. Early intensive vs a delayed conservative
simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to
Z trial. JAMA 2004;292:1307-16 «PMID: 15337732»PubMed
- Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J ym. Long chain omega-3 fatty acids
and cardiovascular disease: a systematic review. Br J Nutr 2012;107 Suppl 2:S201-13
«PMID: 22591894»PubMed
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial
infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio
della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55 «PMID: 10465168»PubMed
- Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes:
the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001;357:905-10
«PMID: 11289345»PubMed
- Heart Protection Study Collaborative Group.. MRC/BHF Heart Protection Study of cholesterol
lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled
trial. Lancet 2002;360:7-22 «PMID: 12114036»PubMed
- Heart Protection Study Collaborative Group.. Randomized trial of the effects of cholesterol-lowering
with simvastatin on peripheral vascular and other major vascular outcomes in 20,536
people with peripheral arterial disease and other high-risk conditions. J Vasc Surg
2007;45:645-654; discussion 653-4 «PMID: 17398372»PubMed
- Hooper L, Martin N, Abdelhamid A ym. Reduction in saturated fat intake for cardiovascular
disease. Cochrane Database Syst Rev 2015;:CD011737 «PMID: 26068959»PubMed
- Hu FB, Manson JE. Omega-3 fatty acids and secondary prevention of cardiovascular disease-is
it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements
(eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular
disease”. Arch Intern Med 2012;172:694-6 «PMID: 22493410»PubMed
- Jakob T, Nordmann AJ, Schandelmaier S ym. Fibrates for primary prevention of cardiovascular
disease events. Cochrane Database Syst Rev 2016;11:CD009753 «PMID: 27849333»PubMed
- Jakobsen MU, Dethlefsen C, Joensen AM ym. Intake of carbohydrates compared with intake
of saturated fatty acids and risk of myocardial infarction: importance of the glycemic
index. Am J Clin Nutr 2010;91:1764-8 «PMID: 20375186»PubMed
- Jakobsen MU, O'Reilly EJ, Heitmann BL ym. Major types of dietary fat and risk of coronary
heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009;89:1425-32
«PMID: 19211817»PubMed
- Josan K, Majumdar SR, McAlister FA. The efficacy and safety of intensive statin therapy:
a meta-analysis of randomized trials. CMAJ 2008;178:576-84 «PMID: 18299547»PubMed
- Joyce NR, Zachariah JP, Eaton CB ym. Statin Use and the Risk of Type 2 Diabetes Mellitus
in Children and Adolescents. Acad Pediatr 2017;17:515-522 «PMID: 28232259»PubMed
- Keech A, Simes RJ, Barter P ym. Effects of long-term fenofibrate therapy on cardiovascular
events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised
controlled trial. Lancet 2005;366:1849-61 «PMID: 16310551»PubMed
- Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins
in adults: another look at a meta-analysis using prediction intervals. Prev Med 2009;49:473-5
«PMID: 19804794»PubMed
- Kelley GA, Kelley KS, Roberts S ym. Comparison of aerobic exercise, diet or both on
lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Clin Nutr 2012;31:156-67 «PMID: 22154987»PubMed
- Kelley GA, Kelley KS. Effects of Diet, Aerobic Exercise, or Both on Non-HDL-C in Adults:
A Meta-Analysis of Randomized Controlled Trials. Cholesterol 2012;2012:840935 «PMID: 23198142»PubMed
- Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins
in adults: a meta-analysis of randomized controlled trials. Prev Med 2009;48:9-19
«PMID: 19013187»PubMed
- Kodama S, Tanaka S, Saito K ym. Effect of aerobic exercise training on serum levels
of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007;167:999-1008
«PMID: 17533202»PubMed
- Koskinen P, Mänttäri M, Manninen V ym. Coronary heart disease incidence in NIDDM patients
in the Helsinki Heart Study. Diabetes Care 1992;15:820-5 «PMID: 1516498»PubMed
- Kwak SM, Myung SK, Lee YJ ym. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic
acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease:
a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern
Med 2012;172:686-94 «PMID: 22493407»PubMed
- LaRosa JC, Deedwania PC, Shepherd J ym. Comparison of 80 versus 10 mg of atorvastatin
on occurrence of cardiovascular events after the first event (from the Treating to
New Targets [TNT] trial). Am J Cardiol 2010;105:283-7 «PMID: 20102935»PubMed
- LaRosa JC, Grundy SM, Waters DD ym. Intensive lipid lowering with atorvastatin in
patients with stable coronary disease. N Engl J Med 2005;352:1425-35 «PMID: 15755765»PubMed
- León H, Shibata MC, Sivakumaran S ym. Effect of fish oil on arrhythmias and mortality:
systematic review. BMJ 2008;337:a2931 «PMID: 19106137»PubMed
- Lin X, Zhang X, Guo J ym. Effects of Exercise Training on Cardiorespiratory Fitness
and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of
Randomized Controlled Trials. J Am Heart Assoc 2015;4: «PMID: 26116691»PubMed
- Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group..
Prevention of cardiovascular events and death with pravastatin in patients with coronary
heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57
«PMID: 9841303»PubMed
- Luirink IK, Wiegman A, Kusters DM ym. 20-Year Follow-up of Statins in Children with
Familial Hypercholesterolemia. N Engl J Med 2019;381:1547-1556 «PMID: 31618540»PubMed
- Manson JE, Cook NR, Lee IM ym. Marine n-3 Fatty Acids and Prevention of Cardiovascular
Disease and Cancer. N Engl J Med 2019;380:23-32 «PMID: 30415637»PubMed
- Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing
polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis
of randomized controlled trials. PLoS Med 2010;7:e1000252 «PMID: 20351774»PubMed
- Nuotio K, Soinne L, Hänninen H ym. Life-threatening coronary disease is prevalent
in patients with stenosing carotid artery disease. Int J Stroke 2015;10:1217-23 «PMID: 26311319»PubMed
- O'Hare F, Spark S, Flanagan Z ym. Impact of informed consent content and length on
recruitment of older adults into a community based primary prevention trial. Contemp
Clin Trials Commun 2018;11:89-94 «PMID: 30003171»PubMed
- O'Keefe JH Jr, Cordain L, Harris WH ym. Optimal low-density lipoprotein is 50 to 70
mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142-6
«PMID: 15172426»PubMed
- ORIGIN Trial Investigators., Bosch J, Gerstein HC ym. n-3 fatty acids and cardiovascular
outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-18 «PMID: 22686415»PubMed
- Palmer SC, Navaneethan SD, Craig JC ym. HMG CoA reductase inhibitors (statins) for
people with chronic kidney disease not requiring dialysis. Cochrane Database Syst
Rev 2014;:CD007784 «PMID: 24880031»PubMed
- Palomäki A , Kovanen P. LDL-kolesterolin luonnonmukainen pitoisuus on saavutettavissa
turvallisesti. Duodecim 2006;122;1747-56
- Pedersen TR, Faergeman O, Kastelein JJ ym. High-dose atorvastatin vs usual-dose simvastatin
for secondary prevention after myocardial infarction: the IDEAL study: a randomized
controlled trial. JAMA 2005;294:2437-45 «PMID: 16287954»PubMed
- Perk J, De Backer G, Gohlke H ym. European Guidelines on cardiovascular disease prevention
in clinical practice (version 2012). The Fifth Joint Task Force of the European Society
of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical
Practice (constituted by representatives of nine societies and by invited experts).
Eur Heart J 2012;33:1635-701 «PMID: 22555213»PubMed
- Ramos R, García-Gil M, Comas-Cufí M ym. Statins for Prevention of Cardiovascular Events
in a Low-Risk Population With Low Ankle Brachial Index. J Am Coll Cardiol 2016;67:630-640
«PMID: 26868687»PubMed
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:
the Scandinavian Simvastatin Survival Study (4S) Lancet 1994;344:1383-9 «PMID: 7968073»PubMed
- Rizos EC, Ntzani EE, Bika E ym. Association between omega-3 fatty acid supplementation
and risk of major cardiovascular disease events: a systematic review and meta-analysis.
JAMA 2012;308:1024-33 «PMID: 22968891»PubMed
- Rodenburg J, Vissers MN, Wiegman A ym. Statin treatment in children with familial
hypercholesterolemia: the younger, the better. Circulation 2007;116:664-8 «PMID: 17664376»PubMed
- Rubins HB, Robins SJ, Collins D ym. Diabetes, plasma insulin, and cardiovascular disease:
subgroup analysis from the Department of Veterans Affairs high-density lipoprotein
intervention trial (VA-HIT). Arch Intern Med 2002;162:2597-604 «PMID: 12456232»PubMed
- Ruppar TM, Conn VS, Chase JA ym. Lipid outcomes from supervised exercise interventions
in healthy adults. Am J Health Behav 2014;38:823-30 «PMID: 25207508»PubMed
- Sacks FM, Pfeffer MA, Moye LA ym. The effect of pravastatin on coronary events after
myocardial infarction in patients with average cholesterol levels. Cholesterol and
Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9 «PMID: 8801446»PubMed
- Saha SA, Arora RR. Fibrates in the prevention of cardiovascular disease in patients
with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled
clinical trials. Int J Cardiol 2010;141:157-66 «PMID: 19232762»PubMed
- Sandhu S, Wiebe N, Fried LF ym. Statins for improving renal outcomes: a meta-analysis.
J Am Soc Nephrol 2006;17:2006-16 «PMID: 16762986»PubMed
- Savarese G, De Ferrari GM, Rosano GM ym. Safety and efficacy of ezetimibe: A meta-analysis.
Int J Cardiol 2015;201:247-52 «PMID: 26301648»PubMed
- Schwab U, Lauritzen L, Tholstrup T ym. Effect of the amount and type of dietary fat
on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular
diseases, and cancer: a systematic review. Food Nutr Res 2014;58: «PMID: 25045347»PubMed
- Schwingshackl L, Dias S, Hoffmann G. Impact of long-term lifestyle programmes on weight
loss and cardiovascular risk factors in overweight/obese participants: a systematic
review and network meta-analysis. Syst Rev 2014;3:130 «PMID: 25358395»PubMed
- Sever PS, Dahlöf B, Poulter NR ym. Prevention of coronary and stroke events with atorvastatin
in hypertensive patients who have average or lower-than-average cholesterol concentrations,
in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA):
a multicentre randomised controlled trial. Lancet 2003;361:1149-58 «PMID: 12686036»PubMed
- Sever PS, Poulter NR, Dahlöf B ym. Reduction in cardiovascular events with atorvastatin
in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering
arm (ASCOT-LLA). Diabetes Care 2005;28:1151-7 «PMID: 15855581»PubMed
- Su X, Zhang L, Lv J ym. Effect of Statins on Kidney Disease Outcomes: A Systematic Review
and Meta-analysis. Am J Kidney Dis 2016;67:881-92 «PMID: 26905361»PubMed
- Taylor F, Huffman MD, Macedo AF ym. Statins for the primary prevention of cardiovascular
disease. Cochrane Database Syst Rev 2013;:CD004816 «PMID: 23440795»PubMed
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction
in incidence of coronary heart disease. JAMA 1984;251:351-64 «PMID: 6361299»PubMed
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship
of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA
1984;251:365-74 «PMID: 6361300»PubMed
- Tikkanen MJ, Szarek M, Fayyad R ym. Total cardiovascular disease burden: comparing
intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease
in End Points Through Aggressive Lipid Lowering) trial. J Am Coll Cardiol 2009;54:2353-7
«PMID: 20082922»PubMed
- Wang D, Liu B, Tao W ym. Fibrates for secondary prevention of cardiovascular disease
and stroke. Cochrane Database Syst Rev 2015;:CD009580 «PMID: 26497361»PubMed
- Wiegman A, Hutten BA, de Groot E ym. Efficacy and safety of statin therapy in children
with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004;292:331-7
«PMID: 15265847»PubMed
- Wiviott SD, Cannon CP, Morrow DA ym. Can low-density lipoprotein be too low? The safety
and efficacy of achieving very low low-density lipoprotein with intensive statin therapy:
a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 2005;46:1411-6 «PMID: 16226163»PubMed
- Vuorio A, Kuoppala J, Kovanen PT ym. Statins for children with familial hypercholesterolemia.
Cochrane Database Syst Rev 2019;2019: «PMID: 31696945»PubMed
- Yamashita S, Masuda D, Matsuzawa Y. Pemafibrate, a New Selective PPARa Modulator:
Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.
Curr Atheroscler Rep 2020;22:5 «PMID: 31974794»PubMed
- Yokoyama M, Origasa H, Matsuzaki M ym. Effects of eicosapentaenoic acid on major coronary
events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded
endpoint analysis. Lancet 2007;369:1090-8 «PMID: 17398308»PubMed
Artikkelin tunnus: nix02847 (050.025)
© 2024 Suomalainen Lääkäriseura Duodecim